Pediatric rheumatology

A novel scoring system based on sIL-2R for predicting intravenous immunoglobulin (IVIG) resistance in Chinese children with Kawasaki disease (KD)

Pediatr Rheumatol Online JPublished Retrospective cohort study

Authors' conclusion

Our newly developed scoring system utilizing sIL-2R demonstrated superior predictive performance in identifying IVIG resistance among Chinese patients with KD.

Study context

Population
Chinese children with Kawasaki disease treated at a cardiovascular medical ward, January 2020 to December 202242 IVIG-resistant
Participants
521 children
Exposure
Novel sIL-2R-based score vs Egami, Formosa, Harada, Kobayashi, Lan and Yang scores for predicting IVIG resistance
Outcome
Prediction of resistance to IVIG (sensitivity and specificity)
Methodological detailssingle-centre, development of a predictive scoring system, comparison with six established scoring systems
  • Single-centre
  • Development of a predictive scoring system
  • Comparison with six established scoring systems

Main finding

As reported in the abstract

Prediction of IVIG resistance: sensitivity and specificity
GroupSensitivitySpecificity
Novel sIL-2R score69.29%83.91%
Egami38.10%88.52%
Formosa95.24%41.13%
Harada78.57%43.22%
Kobayashi66.67%74.95%
Lan66.67%73.49%
Yang69.05%77.24%

Sensitivity

Novel sIL-2R score69.29%
Egami38.10%
Formosa95.24%
Harada78.57%
Kobayashi66.67%
Lan66.67%
Yang69.05%

Specificity

Novel sIL-2R score83.91%
Egami88.52%
Formosa41.13%
Harada43.22%
Kobayashi74.95%
Lan73.49%
Yang77.24%

Observational data: associations, not effects.

Further findings

IVIG resistance incidence

IVIG-resistant KD patients
42 (8.06%)

Coronary arterial lesions in IVIG-resistant KD patients

IVIG-resistant patients at increased risk of coronary arterial lesions (CALs)
P = 0.001

Original publication

A novel scoring system based on sIL-2R for predicting IVIG resistance in Chinese children with KD. Pediatr Rheumatol Online J. Published 18 August 2024. doi:10.1186/s12969-024-01015-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.